This happened to AMRN last week and now it's full steam north for AMRN and ARNA. GLTA and stay long, these two will do great from here on imo, glta longs.
Sentiment: Strong Buy
Thanks for breaking the news. When wall street finds out, we'll run to about $8. Nice to get the inside scoop!!
this craziness will end when FDA sets anchor PDUFA date, but that's a couple months away. And sales should start showing some strength by then too. I tripled up two weeks ago so just riding what I have now, can't add any more or I would at this low pps. gltu
I really think they will. Might be interesting to see if Lovaza sales start dropping as we eat into them. As soon as we show a nice strong, consistent trajectory, AMRN will go up every day. It will happen. I hate seeing it drop too, but the groundwork is laid for a blockbuster and a pps that will exceed $50 within 2 to 3 years. I'm willing to hold on and see it through.
Sentiment: Strong Buy
in retrospect, I wish I had moved evrything here when I originally posted this thread, think NVIV was 1.75 to 1.80 at that time. GLTA longs
I think we get a sales surprise here before long. At some point something good has got to happen for shareholders of a 10bil potential drug.
Sentiment: Strong Buy
those SA bash articles really do work. AMRN has now got to be the absolute best biotech buy available here at $7.50's. unbelivable
Sentiment: Strong Buy
i still firmly believe tht by the end of the year AMRN will be well over $15 afetr FDA anchor trial approval, and sales will have started looking good by then. Vascepa is the far better product with currently over 1bil sales to go after, and close to 10bil after anchor. It will all work out great at some point, But the next big catalyst if we don't get NCE, will be the FDA setting a PDUFA date for anchor. That's about 2 months from now. I will just sit back and trust my dd on this one. In the meantime, my NVIV has very near catalysts that could make it double, so I'll enjoy that one. glta longs, hang in there imo
Sentiment: Strong Buy
yep, good time for a hostile bid like what happened with hgsi. now we need nce approval more than ever to stop the bleeding
Sentiment: Strong Buy
GSK, Pfizer, whoever, make that hostile bid and you will get shareholder support. Go ahead, do it now so we can close green today.
Sentiment: Strong Buy
expect each qtr report to look better and better until we show profitability this time next year. These low 8's are the bottom for AMRN imo. (barring overall market crash)
Sentiment: Strong Buy
that's what I'm thinking too. A couple wins from now, we'll be passing $10
Sentiment: Strong Buy
i've been in NVIV for a long time now. Looks like they are finally on the verge of starting human trials. I think it's a great buy considering the potential and the large pipeline coming right behind the spinal scaffolding. gltu
long AMRN, ARNA, NVIV
So who got in 2 weeks ago when I told you about NVIV. Still time to get in before human trials are announced. GLTA
Sentiment: Strong Buy
If the market believes that indeed HUD and IDE could get approvals by end of March, then i would not be surprised to see NVIV go well past $2.50 and at least to around $3. Because once they start human trials, we are looking at around $5, and when they announce positive results on humans, we will be looking at around $10. Plus these trials don't take as long as typical drug trials, plus NVIV has so much more coming down the road. Buying at this level could be an amazing opportunity if the company is successful. Anywhere under $2.50 imo is a steal if you truly believe in the companys goals and ability to achieve them.
Sentiment: Strong Buy
I see this as positive. HUD answer from FDA still in play and expected by Mar 9. Recent runup probably due to those who knew IDE re-submission in the works. Uncertainty should be gone, timelines set (assuming no more FDA caused delays). We'll see how the pps responds here shortly.
Sentiment: Strong Buy
lol, it will be ER in Sep before any attention is paid to sales. That will be the first qtrly report to have sales for an entire qtr. And it will be a year and a half before the sales numbers are true, after all the freebies expire. Script numbers and Anchor will move this until then. i don't expect any drop.
Sentiment: Strong Buy
maybe Thurs morning we get the DEA go ahead??
yes completely agree. hanging in here hoping to see a nice final judgement award for VRNG. In the meantime, looks like ARNA and AMRN are finally headed north.
Sentiment: Strong Buy
sure looks like some good news coming, we'll see